Literature DB >> 34748149

Conflicts of Interest in Psychopharmacology Textbooks.

Lisa Cosgrove1, Farahdeba Herrawi2, Allen F Shaughnessy3.   

Abstract

While most medical journals require disclosures of industry payments to authors and editors, there is no requirement for textbooks. In this study we evaluated nine well-known psychopharmacology textbooks to identify payments to their writers and editors. Two-thirds of the textbooks had at least one editor or author who received personal payments from one or more pharmaceutical companies, for a total of 11,021,409 USD paid to 11 of 21 editors/authors over a seven-year period. Much of this money was paid to a single author but 24% of the writers received over 75,000 USD each over this time period. There are several psychopharmacology textbooks authored by writers without apparent financial conflicts of interest. Just as with medical journals, medical textbooks should be transparent about payments made to their authors and editors.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Conflict of interest; Disclosure; Medical education/textbooks; Pharmaceutical industry; Psychopharmacology

Mesh:

Year:  2021        PMID: 34748149     DOI: 10.1007/s10597-021-00906-6

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  15 in total

1.  All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.

Authors:  Dana Katz; Arthur L Caplan; Jon F Merz
Journal:  Am J Bioeth       Date:  2003       Impact factor: 11.229

2.  Constructing contentious and noncontentious facts: How gynecology textbooks create certainty around pharma-contraceptive safety.

Authors:  Andrea M Bertotti; Skye A Miner
Journal:  Soc Stud Sci       Date:  2019-03-07       Impact factor: 3.885

3.  Professional Societies Should Abstain From Authorship of Guidelines and Disease Definition Statements.

Authors:  John P A Ioannidis
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-10

4.  Industry sponsorship and research outcome: systematic review with meta-analysis.

Authors:  Andreas Lundh; Joel Lexchin; Barbara Mintzes; Jeppe B Schroll; Lisa Bero
Journal:  Intensive Care Med       Date:  2018-08-21       Impact factor: 17.440

5.  "This may sting a bit": cutting CME's ties to pharma.

Authors:  Adriane Fugh-Berman; Sharon Batt
Journal:  Virtual Mentor       Date:  2006-06-01

6.  Under the Influence: The Interplay among Industry, Publishing, and Drug Regulation.

Authors:  Lisa Cosgrove; Steven Vannoy; Barbara Mintzes; Allen F Shaughnessy
Journal:  Account Res       Date:  2016       Impact factor: 2.622

7.  Effect of exposure to small pharmaceutical promotional items on treatment preferences.

Authors:  David Grande; Dominick L Frosch; Andrew W Perkins; Barbara E Kahn
Journal:  Arch Intern Med       Date:  2009-05-11

8.  Why Having a (Nonfinancial) Interest Is Not a Conflict of Interest.

Authors:  Lisa A Bero; Quinn Grundy
Journal:  PLoS Biol       Date:  2016-12-21       Impact factor: 8.029

9.  Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others.

Authors:  Lisa Bero; Fieke Oostvogel; Peter Bacchetti; Kirby Lee
Journal:  PLoS Med       Date:  2007-06       Impact factor: 11.069

10.  The impact of psychopharmacology on contemporary psychiatry.

Authors:  Ross J Baldessarini
Journal:  Can J Psychiatry       Date:  2014-08       Impact factor: 4.356

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.